Reaction
Enteral Nutrition reporting signals
As of the last recalculation, Enteral Nutrition appears in 556 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is RIVASTIGMINE (PRR 41.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Rivastigmine | 20 | 41.2 | 41.2 |
| Rotigotine | 13 | 34.4 | 34.5 |
| Carbidopa And Levodopa | 39 | 33.0 | 33.0 |
| Cinacalcet Hydrochloride | 38 | 32.7 | 32.7 |
| Rasagiline Mesylate | 8 | 27.3 | 27.3 |
| Levodopa | 5 | 15.6 | 15.6 |
| Palivizumab | 6 | 14.8 | 14.8 |
| Irinotecan Hydrochloride | 5 | 14.7 | 14.7 |
| Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate | 4 | 8.3 | 8.3 |